
Sign up to save your podcasts
Or


BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways
By John Simboli5
77 ratings
BioBoss host John Simboli speaks with Clive Richardson, CEO of Akari Therapeutics, headquartered in London with offices in New York. Hear Clive's thoughts about leadership in biopharma and how Akari Therapeutics is working to develop life-transforming treatments for autoinflammatory diseases involving the complement and leukotriene pathways

3,067 Listeners

1,942 Listeners

1,093 Listeners

2,363 Listeners

945 Listeners

796 Listeners

124 Listeners

321 Listeners

6,074 Listeners

94 Listeners

9,986 Listeners

523 Listeners

146 Listeners

249 Listeners

180 Listeners